XML 78 R54.htm IDEA: XBRL DOCUMENT
v3.23.1

Shareholders' Equity (Details) - Schedule of outstanding options granted | 12 Months Ended
--- | ---
Dec. 31, 2022 $ / shares shares
Option [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 534,826
Options exercisable | 470,710
Option [Member] | October 2013 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,719
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5.06
Options exercisable | 5,719
Exercisable | October 2023
Option [Member] | September 2014 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,719
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5.06
Options exercisable | 5,719
Exercisable | September 2024
Option [Member] | April 2016 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,975
Average Exercise price per share (in Dollars per share) | $ / shares | $ 3.1
Options exercisable | 5,975
Exercisable | April 2026
Option [Member] | December 2016 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 7,170
Average Exercise price per share (in Dollars per share) | $ / shares | $ 3.93
Options exercisable | 7,170
Exercisable | December 2026
Option [Member] | June 2017 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 197,722
Average Exercise price per share (in Dollars per share) | $ / shares | $ 4.1
Options exercisable | 197,722
Exercisable | June 2027
Option [Member] | November 2017 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 17,925
Average Exercise price per share (in Dollars per share) | $ / shares | $ 7.7
Options exercisable | 17,925
Exercisable | November 2027
Option [Member] | August 2019 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 71,700
Average Exercise price per share (in Dollars per share) | $ / shares | $ 8.18
Options exercisable | 71,700
Exercisable | August 2029
Option [Member] | June 2020 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 64,530
Average Exercise price per share (in Dollars per share) | $ / shares | $ 6.62
Options exercisable | 53,724
Exercisable | June 2030
Option [Member] | April 2021 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 62,741
Average Exercise price per share (in Dollars per share) | $ / shares | $ 9.57
Options exercisable | 62,741
Exercisable | April 2031
Option [Member] | August 2021 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 15,000
Average Exercise price per share (in Dollars per share) | $ / shares | $ 8.13
Options exercisable | 6,206
Exercisable | August 2031
Option [Member] | December 2021 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 10,000
Average Exercise price per share (in Dollars per share) | $ / shares | $ 6.8
Options exercisable | 3,300
Exercisable | December 2031
Option [Member] | May 2022 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 65,625
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5
Options exercisable | 32,809
Exercisable | May 2032
Option [Member] | November 2022 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 5,000
Average Exercise price per share (in Dollars per share) | $ / shares | $ 1.05
Exercisable | November 2032
Warrant [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 413,263
Options exercisable | 413,263
Warrant [Member] | August 2019 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 200,596
Average Exercise price per share (in Dollars per share) | $ / shares | $ 15.95
Options exercisable | 200,596
Exercisable | August 2023
Warrant [Member] | September 2020 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 17,925
Average Exercise price per share (in Dollars per share) | $ / shares | $ 16
Options exercisable | 17,925
Exercisable | September 2024
Warrant [Member] | April 2022 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 155,794
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5.14
Options exercisable | 155,794
Exercisable | April 2029
Warrant [Member] | July 2022 [Member] |
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items] |
Options outstanding | 38,948
Average Exercise price per share (in Dollars per share) | $ / shares | $ 5.14
Options exercisable | 38,948
Exercisable | April 2029

X
- Definition Options exercisable. + References No definition available. + Details
Name: | pypd_OptionsExercisable
Namespace Prefix: | pypd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | pypd_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpiration
Namespace Prefix: | pypd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | pypd_ShareholdersEquityDetailsScheduleofoutstandingoptionsgrantedLineItems
Namespace Prefix: | pypd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(iii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_OctoberTwoThousandThirteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_SeptemberTwoThousandFourteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_AprilTwoThousandSixteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_DecemberTwoThousandSixteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_JuneTwoThousandSeventeenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_NovemberTwoThousandSeventeenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_August2019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_JuneTwoThousandTwentyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_April2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_August2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_December2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_May2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_November2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_September2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_April2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=pypd_July2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |